Northern Trust Corp Purchases 6,640 Shares of Waldencast plc (NASDAQ:WALD)

Northern Trust Corp raised its position in shares of Waldencast plc (NASDAQ:WALD) by 4.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 167,662 shares of the company’s stock after buying an additional 6,640 shares during the period. Northern Trust Corp’s holdings in Waldencast were worth $674,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of WALD. Amitell Capital Pte Ltd purchased a new stake in Waldencast during the fourth quarter valued at approximately $780,000. JPMorgan Chase & Co. grew its holdings in Waldencast by 116.3% in the fourth quarter. JPMorgan Chase & Co. now owns 93,561 shares of the company’s stock worth $376,000 after purchasing an additional 50,311 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Waldencast during the fourth quarter worth $70,000. Catalina Capital Group LLC increased its position in shares of Waldencast by 69.9% during the fourth quarter. Catalina Capital Group LLC now owns 27,102 shares of the company’s stock worth $109,000 after purchasing an additional 11,154 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new position in shares of Waldencast during the fourth quarter worth $42,000. 41.97% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

WALD has been the subject of a number of recent analyst reports. Wall Street Zen cut Waldencast from a “hold” rating to a “sell” rating in a research report on Thursday, May 22nd. Canaccord Genuity Group decreased their price target on Waldencast from $6.00 to $5.00 and set a “buy” rating for the company in a research note on Thursday, May 15th. Alliance Global Partners restated a “buy” rating on shares of Waldencast in a research note on Thursday, May 15th. DA Davidson restated a “buy” rating and set a $7.50 price objective on shares of Waldencast in a report on Wednesday, March 19th. Finally, Telsey Advisory Group decreased their price objective on shares of Waldencast from $5.00 to $4.00 and set an “outperform” rating for the company in a research report on Thursday, May 15th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, Waldencast has a consensus rating of “Moderate Buy” and an average target price of $5.11.

Waldencast Stock Performance

Shares of WALD stock opened at $2.72 on Friday. The business has a fifty day moving average of $2.64 and a 200 day moving average of $3.11. Waldencast plc has a 1 year low of $1.98 and a 1 year high of $4.96. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47.

About Waldencast

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.